The GBM cell specificity we observed is consistent with previous reports that the large H2O2 fluxes generated by pharmacological ascorbate treatment are more readily able to be handled by normal cells that have increased levels of catalase and peroxidases (e.g. glutathione peroxidase 1) [14,23]. The gene discussed is GPX1; the disease is glioblastoma.